|
CASP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36319999954893E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51740000004153E-06 |
| Normal-vs-Stage2 |
2.371000E-04 |
| Normal-vs-Stage3 |
3.63130000000655E-05 |
| Normal-vs-Stage4 |
2.21069999972734E-07 |
| Stage1-vs-Stage2 |
5.883200E-01 |
| Stage1-vs-Stage3 |
3.204000E-01 |
| Stage1-vs-Stage4 |
1.930060E-02 |
| Stage2-vs-Stage3 |
7.637600E-01 |
| Stage2-vs-Stage4 |
1.927640E-01 |
| Stage3-vs-Stage4 |
2.850400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.85509999981204E-07 |
| Normal-vs-AfricanAmerican |
1.95191999999844E-05 |
| Normal-vs-Asian |
9.447700E-04 |
| Caucasian-vs-AfricanAmerican |
5.562600E-01 |
| Caucasian-vs-Asian |
1.325830E-01 |
| AfricanAmerican-vs-Asian |
1.747830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.14210000030135E-07 |
| Normal-vs-Female |
2.86010000016823E-07 |
| Male-vs-Female |
4.117800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.356900E-04 |
| Normal-vs-Age(41-60Yrs) |
7.04489999669988E-08 |
| Normal-vs-Age(61-80Yrs) |
4.50320000000559E-06 |
| Normal-vs-Age(81-100Yrs) |
6.169700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.730200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.854800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.314240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.242000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.858190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.055800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.363630E-02 |
| Normal-vs-Grade 2 |
3.83790000000328E-05 |
| Normal-vs-Grade 3 |
4.91889999953976E-07 |
| Normal-vs-Grade 4 |
3.19990001163006E-09 |
| Grade 1-vs-Grade 2 |
8.595600E-01 |
| Grade 1-vs-Grade 3 |
6.678400E-01 |
| Grade 1-vs-Grade 4 |
2.417000E-01 |
| Grade 2-vs-Grade 3 |
6.593800E-01 |
| Grade 2-vs-Grade 4 |
5.259400E-03 |
| Grade 3-vs-Grade 4 |
1.162480E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.602400E-04 |
| Normal-vs-ccB subtype |
2.15490003618868E-09 |
| ccA subtype-vs-ccB subtype |
1.97782999999951E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.89539999993083E-07 |
| Normal-vs-N1 |
6.444200E-03 |
| N0-vs-N1 |
5.615700E-02 |
|
|
